Mark Wheeldon is the founder and CEO of Formedix. He is an active supporter of the Clinical Data Interchange Standards Consortium (CDISC) which Formedix has been a member of since its inception two decades ago. Mark is a member of the CDISC Industry Advisory Council (CAC), and firmly believes that a more efficient end-to-end clinical trial process lies in the successful implementation of data standards and clinical trial automation technologies